Genome-Wide Association Analysis in Primary Sclerosing Cholangitis

Chapman, 1980, Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology, Gut, 21, 870, 10.1136/gut.21.10.870 Boberg, 1998, Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population, Scand J Gastroenterol, 33, 99, 10.1080/00365529850166284 Bambha, 2003, Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community, Gastroenterology, 125, 1364, 10.1016/j.gastro.2003.07.011 Soetikno, 2002, Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis, Gastrointest Endosc, 56, 48, 10.1067/mge.2002.125367 Bergquist, 2008, Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis, Clin Gastroenterol Hepatol, 6, 939, 10.1016/j.cgh.2008.03.016 Schrumpf, 1982, HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease, Scand J Gastroenterol, 17, 187, 10.3109/00365528209182038 Karlsen, 2007, Genetic epidemiology of primary sclerosing cholangitis, World J Gastroenterol, 13, 5421, 10.3748/wjg.v13.i41.5421 Horton, 2004, Gene map of the extended human MHC, Nat Rev Genet, 5, 889, 10.1038/nrg1489 Franke, 2008, Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis, Nat Genet, 40, 713, 10.1038/ng.148 Fisher, 2008, Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease, Nat Genet, 40, 710, 10.1038/ng.145 Silverberg, 2009, Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study, Nat Genet, 41, 216, 10.1038/ng.275 Franke, 2008, Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility, Nat Genet, 40, 1319, 10.1038/ng.221 Purcell, 2007, PLINK: a tool set for whole-genome association and population-based linkage analyses, Am J Hum Genet, 81, 559, 10.1086/519795 2007, Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls, Nature, 447, 661, 10.1038/nature05911 Fukushima, 2006, Bioinformatic approach for understanding the heterogeneity of cholangiocytes, World J Gastroenterol, 12, 3481, 10.3748/wjg.v12.i22.3481 Wang, 2003, A PCR primer bank for quantitative gene expression analysis, Nucleic Acids Res, 31, e154, 10.1093/nar/gng154 Baranzini, 2009, Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis, Hum Mol Genet, 18, 767, 10.1093/hmg/ddn388 Comabella, 2008, Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms, PLoS ONE, 3, e3490, 10.1371/journal.pone.0003490 Weersma, 2009, Confirmation of multiple Crohn's disease susceptibility loci in a large Dutch-Belgian cohort, Am J Gastroenterol, 104, 630 Filmus, 2008, Glypicans, Genome Biol, 9, 224, 10.1186/gb-2008-9-5-224 Capurro, 2003, Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma, Gastroenterology, 125, 89, 10.1016/S0016-5085(03)00689-9 Goyette, 2008, Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis, Mucosal Immunol, 1, 131, 10.1038/mi.2007.15 Capurro, 2005, Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling, Cancer Res, 65, 6245, 10.1158/0008-5472.CAN-04-4244 Maruyama, 2002, Identification of membrane-type receptor for bile acids (M-BAR), Biochem Biophys Res Commun, 298, 714, 10.1016/S0006-291X(02)02550-0 Keitel, 2008, Expression and function of the bile acid receptor TGR5 in Kupffer cells, Biochem Biophys Res Commun, 372, 78, 10.1016/j.bbrc.2008.04.171 Keitel, 2007, The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells, Hepatology, 45, 695, 10.1002/hep.21458 Keitel, 2009, The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders, Hepatology, 50, 861, 10.1002/hep.23032 Pall, 2007, Primary sclerosing cholangitis in childhood is associated with abnormalities in cystic fibrosis-mediated chloride channel function, J Pediatr, 151, 255, 10.1016/j.jpeds.2007.03.062 Zhou, 2002, Activation of the RON receptor tyrosine kinase by macrophage-stimulating protein inhibits inducible cyclooxygenase-2 expression in murine macrophages, J Biol Chem, 277, 38104, 10.1074/jbc.M206167200 Karlsen, 2007, Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis, J Hepatol, 46, 899, 10.1016/j.jhep.2007.01.032 Vandiedonck, 2004, Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia, Proc Natl Acad Sci U S A, 101, 15464, 10.1073/pnas.0406756101 Loftus, 2005, PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis, Gut, 54, 91, 10.1136/gut.2004.046615 Karlsen, 2007, Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis, Am J Gastroenterol, 102, 115, 10.1111/j.1572-0241.2006.00928.x Bungay, 2008, Prevalence and determinants of primary sclerosing cholangitis in a cohort of patients with inflammatory bowel disease and normal liver function tests, Gut, 57, A107 Duerr, 2006, A genome-wide association study identifies IL23R as an inflammatory bowel disease gene, Science, 314, 1461, 10.1126/science.1135245